158 related articles for article (PubMed ID: 35933937)
1. Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
Ma SJ; Yu H; Khan M; Yu B; Santhosh S; Chatterjee U; Gill J; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
Oral Oncol; 2022 Oct; 133():106054. PubMed ID: 35933937
[TBL] [Abstract][Full Text] [Related]
2. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer.
Ma SJ; Yu H; Yu B; Waldman O; Khan M; Chatterjee U; Santhosh S; Gill J; Iovoli AJ; Farrugia M; Shevorykin A; Carl E; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Sheffer C; Warren GW; Singh AK
JAMA Netw Open; 2022 Dec; 5(12):e2245818. PubMed ID: 36480200
[TBL] [Abstract][Full Text] [Related]
3. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer.
Ma SJ; Yu H; Khan M; Gill J; Santhosh S; Chatterjee U; Iovoli A; Farrugia M; Mohammadpour H; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Hicks WL; Platek ME; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2022 Apr; 5(4):e227567. PubMed ID: 35426920
[TBL] [Abstract][Full Text] [Related]
6. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
Shiao JC; Holt D; Ladbury C; Gao D; Jones B; Karam SD; Amini A
Oral Oncol; 2022 Jul; 130():105907. PubMed ID: 35605559
[TBL] [Abstract][Full Text] [Related]
7. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in Metastatic Oropharyngeal Cancer.
Nguy S; Oh C; Karp JM; Wu SP; Li Z; Persky MJ; Hu KS; Givi B; Tam MM
Laryngoscope; 2021 Jun; 131(6):E1847-E1853. PubMed ID: 33141455
[TBL] [Abstract][Full Text] [Related]
9. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
10. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
Front Public Health; 2022; 10():900294. PubMed ID: 35958856
[TBL] [Abstract][Full Text] [Related]
11. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P
Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696
[TBL] [Abstract][Full Text] [Related]
15. Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer.
Zhang Q; Xu T; Shen C; Qian W; Ying H; He X; Wang Y; Ji Q; Hu C; Zhou X; Lu X
Cancer Med; 2023 Apr; 12(8):9175-9185. PubMed ID: 36708134
[TBL] [Abstract][Full Text] [Related]
16. Extracapsular extension is associated with worse distant control and progression-free survival in patients with lymph node-positive human papillomavirus-related oropharyngeal carcinoma.
Shevach J; Bossert A; Bakst RL; Liu J; Misiukiewicz K; Beyda J; Miles BA; Genden E; Posner MR; Gupta V
Oral Oncol; 2017 Nov; 74():56-61. PubMed ID: 29103752
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
Guo TW; Saiyed F; Yao CMKL; Kiong KL; Martinez J; Sacks R; Lee JJ; Moreno AC; Frank SJ; Rosenthal DI; Glisson BS; Ferrarotto R; Mott FE; Johnson FM; Myers JN
Cancer; 2021 Aug; 127(16):2916-2925. PubMed ID: 33873251
[TBL] [Abstract][Full Text] [Related]
18. Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Marcus C; Ciarallo A; Tahari AK; Mena E; Koch W; Wahl RL; Kiess AP; Kang H; Subramaniam RM
J Nucl Med; 2014 Sep; 55(9):1411-6. PubMed ID: 24947059
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
20. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]